Evidence map›Paper›PMID 28884249›Full record

ArticleJournal of computer-aided molecular design2018

CDOCKER and λ-dynamics for prospective prediction in D₃R Grand Challenge 2.

Xinqiang Ding, Ryan L Hayes, Jonah Z Vilseck, Murchtricia K Charles, Charles L Brooks

Abstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. CHARMM-GUIJournal of chemical theory and computation · 2025
    Article
  4. Article
  5. Article
  6. How to Sample Dozens of Substitutions per Site with λ Dynamics.Journal of chemical theory and computation · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xinqiang DingDepartment of Computational Medicine and Bioinformatics, Univeristy of Michigan, Ann Arbor, MI, 48109, USA.
Ryan L HayesDepartment of Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA.
Jonah Z VilseckDepartment of Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA.
Murchtricia K CharlesDepartment of Computational Medicine and Bioinformatics, Univeristy of Michigan, Ann Arbor, MI, 48109, USA.
Charles L BrooksDepartment of Computational Medicine and Bioinformatics, Univeristy of Michigan, Ann Arbor, MI, 48109, USA. brookscl@umich.edu.ORCID 0000-0002-8149-5417

Funding

Theoretical Studies of Receptor-Ligand InteractionsR01GM037554 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROOKS, CHARLES L · 1987 to 2018
$3.8M
Acid-mediated processes in nucleic acids and proteinsR01GM107233 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROOKS, CHARLES L · 2014 to 2017
$1.1M
NIGMS NIH HHS R01 GM037554NIGMS NIH HHS R01 GM107233
6 · The paper itself

Abstract

The opportunity to prospectively predict ligand bound poses and free energies of binding to the Farnesoid X Receptor in the D3R Grand Challenge 2 provided a useful exercise to evaluate CHARMM based docking (CDOCKER) and [Formula: see text]-dynamics methodologies for use in "real-world" applications in computer aided drug design. In addition to measuring their current performance, several recent methodological developments have been analyzed retrospectively to highlight best procedural practices in future applications. For pose prediction with CDOCKER, when the protein structure used for rigid receptor docking was close to the crystallographic holo structure, reliable poses were obtained. Benzimidazoles, with a known holo receptor structure, were successfully docked with an average RMSD of 0.97 [Formula: see text]. Other non-benzimidazole ligands displayed less accuracy largely because the receptor structures we chose for docking were too different from the experimental holo structures. However, retrospective analysis has shown that when these ligands were re-docked into their holo structures, the average RMSD dropped to 1.18 [Formula: see text] for all ligands. When sulfonamides and spiros were docked with the apo structure, which agrees more with their holo structure than the structures we chose, five out of six ligands were correctly docked. These docking results emphasize the need for flexible receptor docking approaches. For [Formula: see text]-dynamics techniques, including multisite [Formula: see text]-dynamics (MS[Formula: see text]D), reasonable agreement with experiment was observed for the 33 ligands investigated; root mean square errors of 2.08 and 1.67 kcal/mol were obtained for free energy sets 1 and 2, respectively. Retrospectively, soft-core potentials, adaptive landscape flattening, and biasing potential replica exchange (BP-REX) algorithms were critical to model large substituent perturbations with sufficient precision and within restrictive timeframes, such as was required with participation in Grand Challenge 2. These developments, their associated benefits, and proposed procedures for their use in future applications are discussed.

Indexed as

Drug DiscoveryMolecular Docking SimulationBenzimidazolesBinding SitesComputer-Aided DesignCrystallography, X-RayDrug DesignHumansIsoxazolesLigandsProtein BindingProtein ConformationReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearSpiro CompoundsSulfonamidesBenzimidazolesIsoxazolesLigandsReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearSpiro CompoundsSulfonamidesCDOCKERD3RDrug design data resourcesdynamicsFree energy calculationProtein-ligand docking

Identifiers

PMID28884249
PMCPMC5767529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.